Positron Emission Tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma

Voichita Bar-Ad, Mark Mishra, Nitin Ohri, Charles Intenzo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: The objective of the current review was to assess published data on the role of Positron Emission Tomography (PET) for evaluation of nodal residual disease after definitive chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC). Methods: Studies were identified by searching PubMed electronic databases. Only studies using a post-chemoradiotherapy PET for nodal residual disease evaluation were included in the present review. Both prospective and retrospective studies were included. Information regarding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET for detecting nodal residual disease after definitive chemoradiotherapy for HNSCC was extracted and analyzed. Results: Twenty published studies were included in the present review. Existing data suggest that a negative postchemoradiotherapy PET scan is associated with a negative predictive value up to 100%. The sensitivity of PET in detecting nodal residual disease is greater for scans performed > 10 weeks after definitive treatment with chemoradiotherapy for HNSCC. Conclusions: Further studies are needed to quantify the reliability of PET in detecting nodal residual disease after chemoradiotherapy for locoregionally advanced HNSCC. The optimal timing of PET imaging after chemoradiotherapy remains to be defined.

Original languageEnglish (US)
Pages (from-to)36-41
Number of pages6
JournalReviews on Recent Clinical Trials
Volume7
Issue number1
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

Chemoradiotherapy
Positron-Emission Tomography
Neck
Therapeutics
Carcinoma, squamous cell of head and neck
PubMed
Retrospective Studies
Databases
Prospective Studies
Sensitivity and Specificity

Keywords

  • Head and Neck Cancer
  • Neck Dissection
  • Positron Emission Tomography

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology

Cite this

Positron Emission Tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma. / Bar-Ad, Voichita; Mishra, Mark; Ohri, Nitin; Intenzo, Charles.

In: Reviews on Recent Clinical Trials, Vol. 7, No. 1, 02.2012, p. 36-41.

Research output: Contribution to journalArticle

@article{fa21e4af27ee4dd19510e6340f9d97db,
title = "Positron Emission Tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma",
abstract = "Objectives: The objective of the current review was to assess published data on the role of Positron Emission Tomography (PET) for evaluation of nodal residual disease after definitive chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC). Methods: Studies were identified by searching PubMed electronic databases. Only studies using a post-chemoradiotherapy PET for nodal residual disease evaluation were included in the present review. Both prospective and retrospective studies were included. Information regarding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET for detecting nodal residual disease after definitive chemoradiotherapy for HNSCC was extracted and analyzed. Results: Twenty published studies were included in the present review. Existing data suggest that a negative postchemoradiotherapy PET scan is associated with a negative predictive value up to 100{\%}. The sensitivity of PET in detecting nodal residual disease is greater for scans performed > 10 weeks after definitive treatment with chemoradiotherapy for HNSCC. Conclusions: Further studies are needed to quantify the reliability of PET in detecting nodal residual disease after chemoradiotherapy for locoregionally advanced HNSCC. The optimal timing of PET imaging after chemoradiotherapy remains to be defined.",
keywords = "Head and Neck Cancer, Neck Dissection, Positron Emission Tomography",
author = "Voichita Bar-Ad and Mark Mishra and Nitin Ohri and Charles Intenzo",
year = "2012",
month = "2",
doi = "10.2174/157488712799363226",
language = "English (US)",
volume = "7",
pages = "36--41",
journal = "Reviews on Recent Clinical Trials",
issn = "1574-8871",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Positron Emission Tomography for neck evaluation following definitive treatment with chemoradiotherapy for locoregionally advanced head and neck squamous cell carcinoma

AU - Bar-Ad, Voichita

AU - Mishra, Mark

AU - Ohri, Nitin

AU - Intenzo, Charles

PY - 2012/2

Y1 - 2012/2

N2 - Objectives: The objective of the current review was to assess published data on the role of Positron Emission Tomography (PET) for evaluation of nodal residual disease after definitive chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC). Methods: Studies were identified by searching PubMed electronic databases. Only studies using a post-chemoradiotherapy PET for nodal residual disease evaluation were included in the present review. Both prospective and retrospective studies were included. Information regarding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET for detecting nodal residual disease after definitive chemoradiotherapy for HNSCC was extracted and analyzed. Results: Twenty published studies were included in the present review. Existing data suggest that a negative postchemoradiotherapy PET scan is associated with a negative predictive value up to 100%. The sensitivity of PET in detecting nodal residual disease is greater for scans performed > 10 weeks after definitive treatment with chemoradiotherapy for HNSCC. Conclusions: Further studies are needed to quantify the reliability of PET in detecting nodal residual disease after chemoradiotherapy for locoregionally advanced HNSCC. The optimal timing of PET imaging after chemoradiotherapy remains to be defined.

AB - Objectives: The objective of the current review was to assess published data on the role of Positron Emission Tomography (PET) for evaluation of nodal residual disease after definitive chemoradiotherapy for head and neck squamous cell carcinoma (HNSCC). Methods: Studies were identified by searching PubMed electronic databases. Only studies using a post-chemoradiotherapy PET for nodal residual disease evaluation were included in the present review. Both prospective and retrospective studies were included. Information regarding sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of PET for detecting nodal residual disease after definitive chemoradiotherapy for HNSCC was extracted and analyzed. Results: Twenty published studies were included in the present review. Existing data suggest that a negative postchemoradiotherapy PET scan is associated with a negative predictive value up to 100%. The sensitivity of PET in detecting nodal residual disease is greater for scans performed > 10 weeks after definitive treatment with chemoradiotherapy for HNSCC. Conclusions: Further studies are needed to quantify the reliability of PET in detecting nodal residual disease after chemoradiotherapy for locoregionally advanced HNSCC. The optimal timing of PET imaging after chemoradiotherapy remains to be defined.

KW - Head and Neck Cancer

KW - Neck Dissection

KW - Positron Emission Tomography

UR - http://www.scopus.com/inward/record.url?scp=84857400942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857400942&partnerID=8YFLogxK

U2 - 10.2174/157488712799363226

DO - 10.2174/157488712799363226

M3 - Article

C2 - 21864252

AN - SCOPUS:84857400942

VL - 7

SP - 36

EP - 41

JO - Reviews on Recent Clinical Trials

JF - Reviews on Recent Clinical Trials

SN - 1574-8871

IS - 1

ER -